Navigation Links
VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit
Date:2/25/2009

n 80% year over year increase in project backlog (as announced on December 2, 2008)
  • Six phase III contracts under award
  • Issuance of its 10th and 11th patents
  • Opening of a European office
  • Development of a new cardiovascular system which automates the detection of high risk plaques for both ultrasound and magnetic resonance imaging
  • "In early 2008, we announced that we had targeted the fourth quarter of 2008 for the company to be cash flow breakeven on an operating basis(1), I am very pleased to announce that we have achieved this objective," stated Molly Henderson, chief business and financial officer of VirtualScopics, Inc. She continued, "Not only is this an essential milestone for the company, especially in light of the volatility within the financial markets, but also provides us the ability to be self sufficient from a cash perspective which is extremely important for the company and our stockholders." She concluded, "This accomplishment, coupled with meeting our revenue and gross margin targets, has resulted in us delivering our strongest financial quarter and full year in the company's history."

    Jeff Markin and Molly Henderson will provide a business and 2009 update and discuss these results during the conference call on Thursday, February 26, 2009 at 11:00 a.m. EST. Interested participants should call 877-407-0778 when calling within the United States or 201-689-8565 when calling internationally. There will be a playback available until March 26, 2009. To listen to the playback, please call 877-660-6853 when calling within the United States or 201-612-7415 when calling internationally. For the replay, please use account number: 286, conference ID number: 313687.

    About VirtualScopics, Inc.

    VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualS
    '/>"/>

    SOURCE VirtualScopics, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Nasdaq Grants VirtualScopics Request for Continued Listing
    2. VirtualScopics Schedules Fourth Quarter 2008 Earnings Announcement
    3. Pharsight Achieves First License Sale for Public-Source Database
    4. GenoLogics Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform
    5. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
    6. Signalife Achieves $1.98 Million Sales Orders Thus Far
    7. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
    8. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
    9. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
    10. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
    11. NOLabs AB Achieves Break-Through in Fight Against MRSA-Bacteria
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... (PRWEB) October 22, 2014 Involution ... the release of a new infographic, Understanding Ebola ... create a beautifully designed, easy to follow informative tool ... areas of outbreak, symptoms and prevention. , "As the ... that the 2014 Ebola outbreak represents not only a ...
    (Date:10/22/2014)... 2014 Grace Century, a private equity ... announces the addition of Dr. Yousef “Josh” Siddiqui ... team. Dr. Siddiqui will provide further healthcare expertise to ... of University College Medical School in the ... in 2001. With further certification as a General Practitioner ...
    (Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
    (Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
    Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3
    ... LAUSANNE, Switzerland, April 11 Galderma Pharma ... dermatology, today,announced that its U.S. holding company, ... CollaGenex Pharmaceuticals, Inc. (Nasdaq:,CGPI). As a result ... wholly owned,subsidiary of Galderma Laboratories., "We ...
    ... (http://www.spectodesign.com ), a leading Los Angeles branding and ... renowned biomedical research,institute. (http://www.liai.org ), "This ... the content to the user with,high-impact visuals and user-centric ... for Allergy & Immunology,s dedication to,Finding Cures Faster, in ...
    ... Inc. (Nasdaq: PPHM ), a clinical stage ... cancer and,hepatitis C virus infection (HCV), today announced ... of oral and poster presentations,at the 2008 Annual ... being held April 12-16, 2008 in San Diego:, ...
    Cached Biology Technology:Galderma Completes Acquisition of CollaGenex 2Galderma Completes Acquisition of CollaGenex 3Galderma Completes Acquisition of CollaGenex 4La Jolla Institute for Allergy & Immunology Wows With New Website 2Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting 2
    (Date:10/17/2014)... news release is available in German . ... millions of sperms every day in order to reproduce? And ... are the topic of the latest issue of the research ... 2014). The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld ... it is not unusual for a female to copulate with ...
    (Date:10/16/2014)... human body. Battles are won, lost or sometimes ... stalemate—known as tumor dormancy—can last up to 25 ... is poorly understood. , A new computational ... a Professor of Chemistry at Princeton University, may ... the switch to a malignant state. Published today ...
    (Date:10/16/2014)... the bowel lining develops and, in the process, suggested ... The researchers produced evidence that stem cells are responsible ... feature of the bowel lining, and believe these stem ... finding as scientists are still divided on the stem ... Wee Tan and Professor Tony Burgess from the Walter ...
    Breaking Biology News(10 mins):Sperm wars 2Modeling tumor dormancy 2Cryptic clues drive new theory of bowel cancer development 2
    ... Scientists now understand how an important protein converts chemical ... cell division, thanks to a new structural model by ... , The structural model helps solve a scientific mystery: ... functions vital to life. These functions include mitosis, or ...
    ... the first large, single-institution series directly comparing weight-loss ... of Chicago found that a newer operation, the ... the standard operation, the Roux-en-Y gastric bypass. , ... Surgery, the researchers report that the duodenal switch ...
    ... public alike have been acutely aware of the potential ravages ... might still recall the pandemics of 1968 and 1957, it ... on that scale--that causes the most trepidation. ... died from this particular strain of the flu virus in ...
    Cached Biology News:UNC scientists solve mystery of how largest cellular motor protein powers movement 2For super-obese patients, duodenal switch beats gastric bypass 2For super-obese patients, duodenal switch beats gastric bypass 3Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3
    1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
    1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
    Request Info...
    ... Mung Bean Nuclease catalyzes the degradation ... yield 5-phosphoryl terminated products. While the nuclease ... very high concentrations the enzyme degrades double-stranded ... Nuclease has been used for transcript mapping ...
    Biology Products: